The remdesivir market is a focused antiviral therapeutics segment shaped by the long tail of COVID-19 clinical need and the shift from pandemic surge volumes to targeted use in high-risk patients. Remdesivir is an intravenous direct-acting antiviral used in hospitalized settings and, in shorter courses, for select non-hospitalized patients when early treatment is intended to reduce progression...